Search clinical trials for: PI3K Target

Total 6132 results

M.D. Anderson Cancer Center

Terminated

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Advanced Cancers

United States
Novartis Pharmaceuticals

Not yet recruiting

A Study of Clinical Practice and Real-world Care of Patients Treated With mTOR, PI3K, and MEK Inhibitors for Extracranial Vascular Anomalies

Vascular Anomalies
Target PharmaSolutions, Inc.

Recruiting

An Observational Study of Patients With Dermatologic Disease (TARGET-DERM+)

Atopic Dermatitis | Vitiligo | Alopecia Areata | Hidradenitis Suppurativa (HS)

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Not yet recruiting

Ex Vivo Study of hAMSC Secretome in Inflammatory Bowel Disease: Effects on Inflammation and Fibrosis (TARGET) (TARGET)

Inflammatory Bowel Diseases
Charite University, Berlin, Germany

Recruiting

Exspanding the Knowledge About TNPO2-Associated Disorders (Target-TNPO2)

TNPO2

Germany

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe